pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
Vaccine for Triple-Negative Breast Cancer
Triple-Negative Breast Cancer (TNBC)
Flow Pharma Inc
0 catalysts
Preclinical
Vaccine to Target IL15, IL15RA and CD80 for Acute Myeloblastic Leukemia
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
University of California San Francisco
0 catalysts
Marketed
Vaxneuvance
Streptococcal Pneumonia
$MRKMerck & Co., Inc.
0 catalysts
Phase 3
← prev
page 148 of 231
next →
131
Pain89
Neurology1
VerorabVax
Rabies
$SNYSanofi
0 catalysts
Preclinical
Viral Diseases
Coronavirus Disease 2019 (COVID-19)
Max Biopharma Inc
0 catalysts
Marketed
Vyvanse
Vyvanse (lisdexamfetamine)
ADHD, binge eating disorder
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 1
WCK-6777
Pyelonephritis
Wockhardt Ltd
0 catalysts
Preclinical
WOREE/SCAR12 (WWOX Deficiency)
Epileptic Encephalopathy
Mahzi Therapeutics Inc
0 catalysts
Phase 2
WP-1066
Glioblastoma Multiforme (GBM)
$MBRXMoleculin Biotech, Inc.
0 catalysts
Preclinical
WP-1096
Coronavirus Disease 2019 (COVID-19)
$MBRXMoleculin Biotech, Inc.
0 catalysts
Preclinical
WP-1097
Coronavirus Disease 2019 (COVID-19)
$MBRXMoleculin Biotech, Inc.
0 catalysts
Preclinical
WSD-0329
Glioblastoma Multiforme (GBM)
Wayshine Biopharma Inc
0 catalysts
Phase 1
WSD-0628
Astrocytoma
Wayshine Biopharma Inc
0 catalysts
Phase 2
WSD-0922
Non-Small Cell Lung Cancer
Wayshine Biopharma Inc
0 catalysts
Preclinical
WSD-1227
Glioblastoma Multiforme (GBM)
Wayshine Biopharma Inc
0 catalysts
Phase 2
WTX-330
Colorectal Cancer
$HOWLWerewolf Therapeutics, Inc.
0 catalysts
Phase 2
WVE-007
Obesity
$WVEWave Life Sciences Ltd.
0 catalysts
Phase 2
WVEN-531
Duchenne Muscular Dystrophy
$WVEWave Life Sciences Ltd.
0 catalysts
Phase 2
Wiskott-Aldrich Syndrome
Wiskott-Aldrich Syndrome
Thrombopoietin receptor
Genethon SA
0 catalysts
Preclinical
X-004
Hemorrhagic Cystitis (Haemorrhagic Cystitis)
Ixaltis
0 catalysts
Phase 1
XB-010
Endometrial Cancer
$EXELEXELIXIS, INC.
0 catalysts
Phase 1
XB-371
Solid Tumor
$EXELEXELIXIS, INC.
0 catalysts
Phase 1
XB-628
Solid Tumor
$EXELEXELIXIS, INC.
0 catalysts
Preclinical
XBIO-020
Hematological Tumor
$XBIOXenetic Biosciences, Inc.
0 catalysts
Preclinical
XDC Conjugate Drugs
Unspecified
Aojin Life Sciences (Yixing) Co Ltd
0 catalysts
XENON, XE-133
XENON, XE-133 (XENON)
CURIUM
0 catalysts
Phase 3
XG-005
Post-Operative Pain
Xgene Pharmaceutical Inc
0 catalysts
Preclinical
XJ-MK-001
Thrombocytopenia
HemaCell Biotechnology Inc
0 catalysts
Phase 1
XKH-002
Solid Tumor
Zhejiang Xinkanghe Biomedical Technology Co Ltd
0 catalysts
Phase 1
XL-309
Fallopian Tube Cancer
$EXELEXELIXIS, INC.
0 catalysts